Shoulder Innovations reports Q4 EPS (38c), consensus (38c)

Reports Q4 revenue $14.4M, consensus $12.79M. “2025 was a transformational year for Shoulder Innovations (SI). We continued to add new surgeon customers at an accelerated pace, drove rapid commercial adoption of our advanced implant systems, and solidified our position as an innovation leader in the shoulder space, all while beginning our journey as a public company,” said Rob Ball, CEO of Shoulder Innovations. “These efforts culminated in record full-year net revenue of $47.3M, representing an exceptional 50% increase year-over-year, supported by accelerating growth in the second half of the year.”